1. Home
  2. SCLX vs FLYX Comparison

SCLX vs FLYX Comparison

Compare SCLX & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$8.05

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Logo flyExclusive Inc.

FLYX

flyExclusive Inc.

HOLD

Current Price

$2.01

Market Cap

103.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
FLYX
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
90.0M
103.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
FLYX
Price
$8.05
$2.01
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
41.4K
164.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.72
Revenue Next Year
$749.70
$8.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$1.90
52 Week High
$34.27
$8.88

Technical Indicators

Market Signals
Indicator
SCLX
FLYX
Relative Strength Index (RSI) 37.66 35.22
Support Level $7.82 $1.95
Resistance Level $12.30 $2.65
Average True Range (ATR) 0.63 0.20
MACD 0.19 -0.01
Stochastic Oscillator 28.25 2.96

Price Performance

Historical Comparison
SCLX
FLYX

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About FLYX flyExclusive Inc.

flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.

Share on Social Networks: